PMID- 27815070 OWN - NLM STAT- MEDLINE DCOM- 20170522 LR - 20181113 IS - 1090-2104 (Electronic) IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 481 IP - 3-4 DP - 2016 Dec 9 TI - Direct detection of SERCA calcium transport and small-molecule inhibition in giant unilamellar vesicles. PG - 206-211 LID - S0006-291X(16)31702-8 [pii] LID - 10.1016/j.bbrc.2016.10.096 [doi] AB - We have developed a charge-mediated fusion method to reconstitute the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) in giant unilamellar vesicles (GUV). Intracellular Ca(2+) transport by SERCA controls key processes in human cells such as proliferation, signaling, and contraction. Small-molecule effectors of SERCA are urgently needed as therapeutics for Ca(2+) dysregulation in human diseases including cancer, diabetes, and heart failure. Here we report the development of a method for efficiently reconstituting SERCA in GUV, and we describe a streamlined protocol based on optimized parameters (e.g., lipid components, SERCA preparation, and activity assay requirements). ATP-dependent Ca(2+) transport by SERCA in single GUV was detected directly using confocal fluorescence microscopy with the Ca(2+) indicator Fluo-5F. The GUV reconstitution system was validated for functional screening of Ca(2+) transport using thapsigargin (TG), a small-molecule inhibitor of SERCA currently in clinical trials as a prostate cancer prodrug. The GUV system overcomes the problem of inhibitory Ca(2+) accumulation for SERCA in native and reconstituted small unilamellar vesicles (SUV). We propose that charge-mediated fusion provides a widely-applicable method for GUV reconstitution of clinically-important membrane transport proteins. We conclude that GUV reconstitution is a technological advancement for evaluating small-molecule effectors of SERCA. CI - Copyright A(c) 2016 Elsevier Inc. All rights reserved. FAU - Bian, Tengfei AU - Bian T AD - Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, 2231 6th St SE, Minneapolis, MN 55455, United States; State Key Laboratory of Fine Chemicals, R&D Center of Membrane Science and Technology, Dalian University of Technology, Dalian 116024, China. FAU - Autry, Joseph M AU - Autry JM AD - Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St SE, Minneapolis, MN 55455, United States; Biophysical Technology Center, Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St SE, Minneapolis, MN 55455, United States. FAU - Casemore, Denise AU - Casemore D AD - Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, 2231 6th St SE, Minneapolis, MN 55455, United States. FAU - Li, Ji AU - Li J AD - Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St SE, Minneapolis, MN 55455, United States; Biophysical Technology Center, Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St SE, Minneapolis, MN 55455, United States. FAU - Thomas, David D AU - Thomas DD AD - Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St SE, Minneapolis, MN 55455, United States. FAU - He, Gaohong AU - He G AD - State Key Laboratory of Fine Chemicals, R&D Center of Membrane Science and Technology, Dalian University of Technology, Dalian 116024, China. FAU - Xing, Chengguo AU - Xing C AD - Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, 2231 6th St SE, Minneapolis, MN 55455, United States. Electronic address: chengguoxing@cop.ufl.edu. LA - eng GR - R01 CA163864/CA/NCI NIH HHS/United States GR - R01 GM027906/GM/NIGMS NIH HHS/United States GR - R01 HL129814/HL/NHLBI NIH HHS/United States PT - Journal Article DEP - 20161101 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Lipids) RN - 0 (Oleic Acids) RN - 0 (Phosphatidylcholines) RN - 0 (Small Molecule Libraries) RN - 0 (Unilamellar Liposomes) RN - 0 (o-ethyldioleoylphosphatidylcholinium) RN - 67526-95-8 (Thapsigargin) RN - EC 3.6.3.8 (Sarcoplasmic Reticulum Calcium-Transporting ATPases) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/*metabolism MH - Ion Transport/drug effects MH - Lipids/chemistry MH - Microscopy, Fluorescence MH - Oleic Acids/chemistry MH - Phosphatidylcholines/chemistry MH - Rabbits MH - Sarcoplasmic Reticulum Calcium-Transporting ATPases/*metabolism MH - Small Molecule Libraries/*pharmacology MH - Static Electricity MH - Thapsigargin/pharmacology MH - Unilamellar Liposomes/*metabolism PMC - PMC5123963 MID - NIHMS828333 OTO - NOTNLM OT - Biomimetic membrane OT - Calcium regulation OT - Drug discovery OT - Electrostatic fusion OT - Lipid reconstitution OT - Transport proteins EDAT- 2016/11/07 06:00 MHDA- 2017/05/23 06:00 PMCR- 2017/12/09 CRDT- 2016/11/06 06:00 PHST- 2016/10/06 00:00 [received] PHST- 2016/10/12 00:00 [accepted] PHST- 2016/11/07 06:00 [pubmed] PHST- 2017/05/23 06:00 [medline] PHST- 2016/11/06 06:00 [entrez] PHST- 2017/12/09 00:00 [pmc-release] AID - S0006-291X(16)31702-8 [pii] AID - 10.1016/j.bbrc.2016.10.096 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2016 Dec 9;481(3-4):206-211. doi: 10.1016/j.bbrc.2016.10.096. Epub 2016 Nov 1.